A Multicenter Observational Study Evaluating Off-Label Use Of Single-Tablet Regimen (STR) Of Rilpivirine In Combination With Emtricitabine And Tenofovir (RPV/FTC/TDF) In HIV-1-Infected Pediatric Patients.

Trial Profile

A Multicenter Observational Study Evaluating Off-Label Use Of Single-Tablet Regimen (STR) Of Rilpivirine In Combination With Emtricitabine And Tenofovir (RPV/FTC/TDF) In HIV-1-Infected Pediatric Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Feb 2017

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top